These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 20108225

  • 1. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ.
    Hum Brain Mapp; 2010 Oct; 31(10):1542-55. PubMed ID: 20108225
    [Abstract] [Full Text] [Related]

  • 2. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    J Neurol Sci; 2009 Jul 15; 282(1-2):55-60. PubMed ID: 19286193
    [Abstract] [Full Text] [Related]

  • 3. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.
    Neuroimage; 2009 Mar 01; 45(1):60-7. PubMed ID: 19013533
    [Abstract] [Full Text] [Related]

  • 4. Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
    Filli L, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Sprenger T, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.
    Mult Scler; 2012 Nov 01; 18(11):1577-84. PubMed ID: 22495945
    [Abstract] [Full Text] [Related]

  • 5. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 01; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 6. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.
    Riccitelli G, Rocca MA, Pagani E, Martinelli V, Radaelli M, Falini A, Comi G, Filippi M.
    Mult Scler; 2012 Jul 01; 18(7):1027-37. PubMed ID: 22422807
    [Abstract] [Full Text] [Related]

  • 7. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 01; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 8. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar 01; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 9. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.
    Mult Scler; 2014 Feb 01; 20(2):202-13. PubMed ID: 23804554
    [Abstract] [Full Text] [Related]

  • 10. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.
    Ann Neurol; 2008 Sep 01; 64(3):247-54. PubMed ID: 18570297
    [Abstract] [Full Text] [Related]

  • 11. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
    Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.
    Neurology; 2005 Mar 22; 64(6):1001-7. PubMed ID: 15781816
    [Abstract] [Full Text] [Related]

  • 12. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
    Sbardella E, Petsas N, Tona F, Prosperini L, Raz E, Pace G, Pozzilli C, Pantano P.
    PLoS One; 2013 Mar 22; 8(5):e63250. PubMed ID: 23696802
    [Abstract] [Full Text] [Related]

  • 13. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M, Rocca MA, Moiola L, Ghezzi A, Milani N, Veggiotti P, Comi G, Filippi M.
    J Neurol Neurosurg Psychiatry; 2010 Dec 22; 81(12):1357-62. PubMed ID: 20660915
    [Abstract] [Full Text] [Related]

  • 14. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis.
    Mulholland AD, Vitorino R, Hojjat SP, Ma AY, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    AJNR Am J Neuroradiol; 2018 Jan 22; 39(1):91-96. PubMed ID: 29097413
    [Abstract] [Full Text] [Related]

  • 15. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B, Schneider R, Weiler F, Suchan B, Haghikia A, Hoffjan S, Gold R, Köster O, Lukas C.
    Mult Scler Relat Disord; 2015 May 22; 4(3):264-72. PubMed ID: 26008944
    [Abstract] [Full Text] [Related]

  • 16. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
    Preziosa P, Rocca MA, Pagani E, Storelli L, Rodegher M, Moiola L, Filippi M.
    J Neurol Neurosurg Psychiatry; 2020 May 22; 91(5):493-502. PubMed ID: 32111638
    [Abstract] [Full Text] [Related]

  • 17. Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.
    Bussas M, Grahl S, Pongratz V, Berthele A, Gasperi C, Andlauer T, Gaser C, Kirschke JS, Wiestler B, Zimmer C, Hemmer B, Mühlau M.
    Mult Scler; 2022 May 22; 28(6):900-909. PubMed ID: 34591698
    [Abstract] [Full Text] [Related]

  • 18. Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis--a longitudinal MRI study.
    Bendfeldt K, Egger H, Nichols TE, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Radue EW, Borgwardt SJ.
    Brain Res; 2010 Apr 14; 1325():174-82. PubMed ID: 20167205
    [Abstract] [Full Text] [Related]

  • 19. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
    Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H.
    Hum Brain Mapp; 2015 May 14; 36(5):1796-807. PubMed ID: 25627545
    [Abstract] [Full Text] [Related]

  • 20. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.
    Ann Neurol; 2010 Mar 14; 67(3):376-83. PubMed ID: 20373349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.